
    
      It is a multicenter study. 4 different Spain Cystic Fibrosis Foundations are included in the
      study (Madrid, Valencia, Murcia and Arag√≥n). All patients will perform three different arms
      of treatment in a crossover randomization. Each arm of treatment will be apply only in one
      session. The wash-out period will be one week. Before starting the trial, all patients will
      perform a control session without any intervention, only the outcome measures will be assess.

      During the study period the patients' pharmacological treatment remained unchanged
    
  